Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side effects, such as nausea, vomiting, and diarrhea.One is not safer than the other—tolerance to the medications largely depends on the patient.

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the SURMOUNT-5 trial. As Healio previously reported,

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who took semaglutide (Ozempic,

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.

Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about their versions of weight-loss drugs like Ozempic, Wegovy and Mounjaro. These medical spas were offering compounded versions of GLP-1s,

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.